OttavioValerioVitoloMD

Instructor in Psychiatry, Massachusetts General Hospital

Dr. Vitolo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Harvard Medical SchoolM.M.Sc., Translational Medicine, 2010 - 2012
Brigham and Women's HospitalBehavioral Neurology and Neuropsychiatry, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 2004 - 2008
Sapienza University of RomeClass of 1998

MA State Medical License 2008 - 2025
American Board of Psychiatry and Neurology Psychiatry
United Council for Neurologic SubspecialtiesBehavioral Neurology and Neuropsychiatry

PubMed

343 citations
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
Bing Gong, Ottavio V. Vitolo, Fabrizio Trinchese, Shumin Liu, Michael L. Shelanski
The Journal of Clinical Investigation. 2004-12-01
171 citations
Dendrite and dendritic spine alterations in Alzheimer models.
Donna Moolman, Ottavio V. Vitolo, Jean-Paul Vonsattel, Michael L. Shelanski
Journal of Neurocytology. 2004-05-01
416 citations
Functional Alterations in Memory Networks in Early Alzheimer’s Disease
Reisa A. Sperling, Bradford C. Dickerson, Maija Pihlajamäki, Patrizia Vannini, Peter S. LaViolette
Neuromolecular Medicine. 2010-01-13

Relmada Therapeutics Stock Soars on Phase 2 Depression Study ResultsOctober 15th, 2019
Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies ResultsApril 16th, 2019